Skip to main content
OpenTrials

Clinical trial condition

Thrombocythemia, Essential

Explore clinical trials studying Thrombocythemia, Essential. Study availability and eligibility vary by location and protocol.

185 public trials 31 recruiting studies
Refine in advanced search Browse all conditions

Thrombocythemia, Essential trial results

Active, not recruiting

Long-term Study Evaluating the Effect of Givinostat in Patients With Chronic Myeloproliferative Neoplasms

NCT01761968

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
Locations
  • Charite Research Organization GmbH Berlin, Germany
  • Universitaetsklinikum Freiburg, Innere Medizin I - Haematologie und Onkologie Freiburg im Breisgau, Germany
  • Azienda Ospedaliero-Universitaria Policlinico Consorziale, Bari Bari, BA, Italy
  • Istituto Tumori Giovanni Paolo II IRCCS Ospedale Oncologico di Bari Bari, BA, Italy
View all 15 locations
View Trial Details
Active, not recruiting

A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm

NCT04041050

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +22 more
Locations
  • City of Hope /ID# 239769 Duarte, California, United States
  • Providence - St. Jude Medical Center /ID# 242558 Fullerton, California, United States
  • Moores Cancer Center at UC San Diego /ID# 229584 La Jolla, California, United States
  • UCLA /Id# 222784 Los Angeles, California, United States
View all 42 locations
View Trial Details
Active, not recruiting

Unraveling the Role of Extracellular Vesicles-driven Senescence in Myeloproliferative Neoplasms

NCT06798805

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +15 more
Locations
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy
  • ASST Spedali Civili di Brescia Brescia, BS, Italy
  • Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori- IRST Meldola, FC, Italy
  • Ospedale S.Maria delle Croci Ravenna, RA, Italy
View Trial Details
Active, not recruiting

A Study to Evaluate the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythaemia Patients

NCT06514807

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • University Hospital Graz, Department of Internal Medicine, Clinical Department of Hematology Graz, Styria, Austria
  • Medical University Innsbruck, Department of Internal Medicine V (Hematology and Oncology) Innsbruck, Tyrol, Austria
  • Ordensklinikum Linz GmbH Elisabethinen Hospital, Department of Internal Medicine I - Hemato-Oncology Linz, Upper Austria, Austria
  • Medical University Vienna, Department of Internal Medicine I, Clinical Department of Hematology and Hemostaseology Vienna, Austria
View all 36 locations
View Trial Details
Completed

Myeloproliferative Neoplasms: an In-depth Case-control Study

NCT01831635

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
Locations
  • University Hospitals Southampton NHS Foundation Trust Southampton, England, United Kingdom
  • Belfast Health And Social Care Trust Belfast, Northern Ireland, United Kingdom
  • Queen's University Belfast Belfast, Northern Ireland, United Kingdom
View Trial Details
Completed

A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies

NCT02158858

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Disease, +23 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • Northwestern University - Lurie Comprehensive Cancer Center Chicago, Illinois, United States
View all 48 locations
View Trial Details
Completed

Study of Bomedemstat in Participants With Essential Thrombocythemia (IMG-7289-CTP-201/MK-3543-003)

NCT04254978

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Local Institution Jacksonville, Florida, United States
  • Local Institution Ann Arbor, Michigan, United States
  • Local Institution New York, United States
  • Local Institution Durham, North Carolina, United States
View all 26 locations
View Trial Details
Completed

An Extension Study of Bomedemstat (IMG-7289/MK-3543) in Participants With Myeloproliferative Neoplasms (IMG-7289-CTP-202/MK-3543-005)

NCT05223920

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • University of Miami Leonard M. Miller Miami, Florida, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Cleveland Clinic Foundation Cleveland, Ohio, United States
  • UMPC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
View all 19 locations
View Trial Details
Completed

Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders

NCT00588991

Conditions
Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia, Adult Acute Monocytic Leukemia, +55 more
Locations
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
View Trial Details

Related conditions